The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
U.S. needs to pursue evidence-based interventions for substance use disorders. It’s unclear to what degree the Trump ...
Insider activity is seldom enough to move a market independently but can signal how a company’s management thinks. Exclusive content, detailed data sets, and best-in-class trade insights to ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
NY suddenly started withholding names of medical facilities with cases of deadly drug-resistant fungus Candida auris. We got ...
Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...
most notably in a four-part special from 2017 about a mystical, musical land and its five-part, 2020 sequel. Said mystical land is, reportedly, supposed to be the focus of a Cartoon Network ...
The Medicare drug list, also called a formulary, lists the prescription drugs and vaccines that Medicare covers. Medicare provides this coverage through Medicare Part D or Medicare Advantage (also ...
"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...
Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...
Informal drug consumption spaces have existed for a while. An unsanctioned facility, delivered from an old ambulance was briefly operational in Glasgow city centre in 2020-21. However, a wide ...